// App-Quantinova.ai

1067 : New threshold of ER positivity in early stage HER2- breast cancer.

Researchers

Presenter

  • Takeo Fujii

Principal Investigators

  • Takahiro Kogawa

  • Wenli Dong

  • Jennifer Keating Litton

  • Stacy L. Moulder

  • Debu Tripathy

  • Kelly Hunt

  • Takayuki Iwamoto

  • Lajos Pusztai

  • Bora Lim

  • Yu Shen

  • Naoto T. Ueno

Medical Centers

  • The University of Texas MD Anderson Cancer Canter, Houston, TX

  • Department of Breast Surgical Oncology, Division of Surgery, The University of Texas MD Anderson Cancer Center, Houston, TX

  • Okayama University Hospital, Okayama, Japan

  • Yale Cancer Center, New Haven, CT

  • Department of Bioinformatics, The University of Texas MD Anderson Cancer Center, Houston, TX

Locations

  • United States

  • Japan

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Breast cancer

Biomarkers

  • erb-b2 receptor tyrosine kinase 2

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved